Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The welcome news is that the procedure is quick, safe, and administered under a physicians care
Side Effects and Safety: What the Research Shows Available experimental and review data describe GHKCu as noncytotoxic and welltolerated in cell and animal studies (including injectable and topical models) with no significant adverse effects reported at typical research doses
Reports show 87% suppression of microsomal lipid peroxidation, providing a research tool for studying iron-driven oxidative stress in models of aging, ischemia-reperfusion, and neurodegeneration.[8] Comparative Research Context Within the matrix-remodeling and tissue-repair research domain, GHK-Cu is most directly compared with BPC-157 (gastric pentadecapeptide that drives angiogenesis via Egr-1/NAB2 and VEGFR2), TB-500 (thymosin beta-4 fragment that sequesters G-actin and accelerates cell migration), and thymosin alpha-1 (TLR-modulating immunopeptide)
Description GHK-Cu (50mg)/TB-500 (10mg)/BPC-157 (10mg)/KPV(10mg) Blend Peptide 80mg Vial **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form
